SIN16886P Medication Singapore | Medicine SG
SIN16886P is the Singapore licence number of the medication NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED), held by PHARMENG TECHNOLOGY PTE. LTD., approved on 1970-01-01. The dosage in INJECTION, SUSPENSION form, is administered by the INTRAMUSCULAR route. The forensic classification is Prescription Only, and ATC code is J07BN04.
Permalink: https://www.medicinesg.com/sg/meds/sin16886p/
- Licence number: SIN16886P
- Product name: NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED)
- License holder: PHARMENG TECHNOLOGY PTE. LTD.
- Approval date: 1970-01-01
- Forensic classification: Prescription Only
- ATC Code: J07BN04
- Dosage form: INJECTION, SUSPENSION
- Route of Administration: INTRAMUSCULAR
- Manufacturer & Country of manufacturer:
- Active ingredients & Strength: